儿童肺炎支原体肺炎流行病学及发病机制 研究进展
Research Progress on Epidemiology and Pathogenesis of Pediatric Mycoplasma pneumoniae Pneumonia
DOI: 10.12677/acm.2026.1641368, PDF,   
作者: 王凯悦：延安大学医学院，陕西 延安；薛峥峰：延安大学附属医院儿科，陕西 延安
关键词: 肺炎支原体；儿童；致病机制；流行病学；Mycoplasma pneumoniae； Children； Pathogenic Mechanism； Epidemiology
摘要: 肺炎支原体(Mycoplasma pneumoniae, MP)是儿童社区获得性肺炎(Community-acquired pneumonia, CAP)的常见病原体，近年来肺炎支原体肺炎(Mycoplasma pneumoniae pneumonia, MPP)发病率在全球呈上升趋势，重症及难治性病例相关报道增多，其免疫机制复杂，目前尚未完全明确。现针对儿童MPP的流行病学特征、发病机制相关研究进展做一综述。
Abstract: Mycoplasma pneumoniae (MP) is a common pathogen of community-acquired pneumonia (CAP) in children. In recent years, the incidence of Mycoplasma pneumoniae pneumonia (MPP) has been on the rise globally, with an increasing number of reports on severe and refractory cases. Its immune mechanisms are complex and have not yet been fully clarified. This review focuses on the epidemiological characteristics and research progress related to the pathogenesis of MPP in children.
文章引用：王凯悦, 薛峥峰. 儿童肺炎支原体肺炎流行病学及发病机制 研究进展[J]. 临床医学进展, 2026, 16(4): 1359-1365. https://doi.org/10.12677/acm.2026.1641368

参考文献

[1] Roh, E.J., Lee, M., Lee, J.Y., Kim, H., Ahn, Y.M., Kim, J.K., et al. (2022) Analysis of National Surveillance of Respiratory Pathogens for Community-Acquired Pneumonia in Children and Adolescents. BMC Infectious Diseases, 22, Article No. 330. [Google Scholar] [CrossRef] [PubMed]
[2] 丁杰, 张冰, 宋爱琴. 阿奇霉素联合大剂量维生素C治疗儿童肺炎支原体肺炎的临床效果及对外周血T淋巴细胞亚群、炎性因子及相关蛋白的影响[J]. 实用临床医药杂志, 2024, 28(14): 54-59+66.
[3] 中华医学会儿科学分会呼吸学组, 《中华实用儿科临床杂志》编辑委员会. 儿童肺炎支原体肺炎诊治专家共识(2015年版) [J]. 中华实用儿科临床杂志, 2015, 30(17): 1304-1308.
[4] 赵顺英, 钱素云, 陈志敏, 等. 儿童肺炎支原体肺炎诊疗指南(2023年版) [J]. 传染病信息, 2023, 36(4): 291-297.
[5] Waites, K.B., Xiao, L., Liu, Y., Balish, M.F. and Atkinson, T.P. (2017) Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clinical Microbiology Reviews, 30, 747-809. [Google Scholar] [CrossRef] [PubMed]
[6] Edouard, S., Boughammoura, H., Colson, P., La Scola, B., Fournier, P. and Fenollar, F. (2024) Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023-2024. Emerging Infectious Diseases, 30, 1481-1484. [Google Scholar] [CrossRef] [PubMed]
[7] Bradley, J.S., Byington, C.L., Shah, S.S., Alverson, B., Carter, E.R., Harrison, C., et al. (2011) Executive Summary: The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clinical Infectious Diseases, 53, 617-630. [Google Scholar] [CrossRef] [PubMed]
[8] Kutty, P.K., Jain, S., Taylor, T.H., Bramley, A.M., Diaz, M.H., Ampofo, K., et al. (2018) Mycoplasma pneumoniae among Children Hospitalized with Community-Acquired Pneumonia. Clinical Infectious Diseases, 68, 5-12. [Google Scholar] [CrossRef] [PubMed]
[9] Lind, K., Benzon, M.W., Jensen, S. and Clyde, W.A. (1997) A Seroepidemiological Study of Mycoplasma pneumoniae Infections in Denmark over the 50-Year Period 1946-1995. European Journal of Epidemiology, 13, 581-586. [Google Scholar] [CrossRef] [PubMed]
[10] Lenglet, A., Herrador, Z., Magiorakos, A.P., Leitmeyer, K., Coulombier, D. and European Working Group on Mycoplasma pneumoniae Surveillance, C. (2012) Surveillance Status and Recent Data for Mycoplasma pneumoniae Infections in the European Union and European Economic Area, January 2012. Eurosurveillance, 17, Article No. 20075. [Google Scholar] [CrossRef] [PubMed]
[11] Meyer Sauteur, P.M., Beeton, M.L., Uldum, S.A., Bossuyt, N., Vermeulen, M., Loens, K., et al. (2022) Mycoplasma pneumoniae Detections before and during the COVID-19 Pandemic: Results of a Global Survey, 2017 to 2021. Eurosurveillance, 27, Article ID: 2100746. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, M., Li, Y., Shi, Y., Liu, H., Tong, X., Ma, L., et al. (2024) Molecular Epidemiology of Mycoplasma pneumoniae Pneumonia in Children, Wuhan, 2020-2022. BMC Microbiology, 24, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[13] Zhao, F., Liu, G., Cao, B., Wu, J., Gu, Y., He, L., et al. (2013) Multiple-Locus Variable-Number Tandem-Repeat Analysis of 201 Mycoplasma pneumoniae Isolates from Beijing, China, from 2008 to 2011. Journal of Clinical Microbiology, 51, 636-639. [Google Scholar] [CrossRef] [PubMed]
[14] Nordholm, A.C., Søborg, B., Jokelainen, P., Lauenborg Møller, K., Flink Sørensen, L., Grove Krause, T., et al. (2024) Mycoplasma pneumoniae Epidemic in Denmark, October to December, 2023. Eurosurveillance, 29, Article ID: 2300707. [Google Scholar] [CrossRef] [PubMed]
[15] de Groot, R.C.A., Streng, B.M.M., Bont, L.J., Meyer Sauteur, P.M. and van Rossum, A.M.C. (2025) Resurgence of Mycoplasma pneumoniae Infections in Children: Emerging Challenges and Opportunities. Current Opinion in Infectious Diseases, 38, 468-476. [Google Scholar] [CrossRef] [PubMed]
[16] Méndez-Echevarría, A., Calle-Miguel, L., Miralbés, S., Barreiro-Pérez, S., Afonso-Rodriguez, O., Soler-Simón, J.A., et al. (2024) Increased Severity of Mycoplasma pneumoniae Infections in Spanish Children. Pediatric Infectious Disease Journal, 43, 1113-1119. [Google Scholar] [CrossRef] [PubMed]
[17] Xu, Y., Yang, C., Sun, P., Zeng, F., Wang, Q., Wu, J., et al. (2024) Epidemic Features and Megagenomic Analysis of Childhood Mycoplasma pneumoniae Post COVID-19 Pandemic: A 6-Year Study in Southern China. Emerging Microbes & Infections, 13, Article ID: 2353298. [Google Scholar] [CrossRef] [PubMed]
[18] Taborda, I., Tomé, R., Santos Ferreira, C., Oliveira Inácio, R., Vaz, J., Carmo, A., et al. (2025) No Increase in Severity of Mycoplasma pneumoniae: Insights from the Postpandemic Epidemic. Pediatric Infectious Disease Journal, 44, e24-e26. [Google Scholar] [CrossRef] [PubMed]
[19] Dungu, K.H.S., Holm, M., Hartling, U., Jensen, L.H., Nielsen, A.B., Schmidt, L.S., et al. (2024) Mycoplasma pneumoniae Incidence, Phenotype, and Severity in Children and Adolescents in Denmark Before, During, and after the COVID-19 Pandemic: A Nationwide Multicentre Population-Based Cohort Study. The Lancet Regional Health-Europe, 47, Article ID: 101103. [Google Scholar] [CrossRef] [PubMed]
[20] Talkington, D.F., Waites, K.B., Schwartz, S.B. and Besser, R.E. (2001) Emerging from Obscurity: Understanding Pulmonary and Extrapulmonary Syndromes, Pathogenesis, and Epidemiology of Human Mycoplasma pneumoniae Infections. In: Scheld, W.M., Craig, W.A. and Hughes, J.M., Eds., Emerging Infections 5, ASM Press, 57-84.
[21] Dallo, S.F., Chavoya, A. and Baseman, J.B. (1990) Characterization of the Gene for a 30-Kilodalton Adhesion-Related Protein of Mycoplasma pneumoniae. Infection and Immunity, 58, 4163-4165. [Google Scholar] [CrossRef] [PubMed]
[22] Krause, D.C. (1996) Mycoplasma pneumoniae Cytadherence: Unravelling the Tie That Binds. Molecular Microbiology, 20, 247-253. [Google Scholar] [CrossRef] [PubMed]
[23] Haodang, L., Lianmei, Q., Ranhui, L., Liesong, C., Jun, H., Yihua, Z., et al. (2019) HO-1 Mediates the Anti-Inflammatory Actions of Sulforaphane in Monocytes Stimulated with a Mycoplasmal Lipopeptide. Chemico-Biological Interactions, 306, 10-18. [Google Scholar] [CrossRef] [PubMed]
[24] Hardy, R.D., Coalson, J.J., Peters, J., Chaparro, A., Techasaensiri, C., Cantwell, A.M., et al. (2009) Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin. PLOS ONE, 4, e7562. [Google Scholar] [CrossRef] [PubMed]
[25] Wen, Y., Zhai, Y., Sang, S., Cao, C., Mao, Y., Hu, E., et al. (2026) Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia. Microorganisms, 14, Article No. 229. [Google Scholar] [CrossRef] 
[26] Kannan, T.R. and Baseman, J.B. (2006) ADP-Ribosylating and Vacuolating Cytotoxin of Mycoplasma pneumoniae Represents Unique Virulence Determinant among Bacterial Pathogens. Proceedings of the National Academy of Sciences, 103, 6724-6729. [Google Scholar] [CrossRef] [PubMed]
[27] Becker, A., Kannan, T.R., Taylor, A.B., Pakhomova, O.N., Zhang, Y., Somarajan, S.R., et al. (2015) Structure of CARDS Toxin, a Unique ADP-Ribosylating and Vacuolating Cytotoxin from Mycoplasma pneumoniae. Proceedings of the National Academy of Sciences, 112, 5165-5170. [Google Scholar] [CrossRef] [PubMed]
[28] Medina, J.L., Coalson, J.J., Brooks, E.G., Le Saux, C.J., Winter, V.T., Chaparro, A., et al. (2014) Mycoplasma pneumoniae CARDS Toxin Exacerbates Ovalbumin-Induced Asthma-Like Inflammation in BALB/c Mice. PLOS ONE, 9, e102613. [Google Scholar] [CrossRef] [PubMed]
[29] Techasaensiri, C., Tagliabue, C., Cagle, M., Iranpour, P., Katz, K., Kannan, T.R., et al. (2010) Variation in Colonization, ADP-Ribosylating and Vacuolating Cytotoxin, and Pulmonary Disease Severity among Mycoplasma pneumoniae Strains. American Journal of Respiratory and Critical Care Medicine, 182, 797-804. [Google Scholar] [CrossRef] [PubMed]
[30] Johnson, C., Kannan, T.R. and Baseman, J.B. (2011) Cellular Vacuoles Induced by Mycoplasma pneumoniae CARDS Toxin Originate from Rab9-Associated Compartments. PLOS ONE, 6, e22877. [Google Scholar] [CrossRef] [PubMed]
[31] Reynolds, J.M., Pappu, B.P., Peng, J., Martinez, G.J., Zhang, Y., Chung, Y., et al. (2010) Toll-Like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease. Immunity, 32, 692-702. [Google Scholar] [CrossRef] [PubMed]
[32] Wei, R., Dong, L., Xiao, Q., Sun, D., Li, X. and Nian, H. (2014) Engagement of Toll-Like Receptor 2 Enhances Interleukin (IL)-17+ Autoreactive T Cell Responses via P38 Mitogen-Activated Protein Kinase Signalling in Dendritic Cells. Clinical and Experimental Immunology, 178, 353-363. [Google Scholar] [CrossRef] [PubMed]
[33] Wilson, A.S., Randall, K.L., Pettitt, J.A., Ellyard, J.I., Blumenthal, A., Enders, A., et al. (2022) Neutrophil Extracellular Traps and Their Histones Promote Th17 Cell Differentiation Directly via TLR2. Nature Communications, 13, Article No. 528. [Google Scholar] [CrossRef] [PubMed]
[34] Narita, M. (2010) Pathogenesis of Extrapulmonary Manifestations of Mycoplasma pneumoniae Infection with Special Reference to Pneumonia. Journal of Infection and Chemotherapy, 16, 162-169. [Google Scholar] [CrossRef] [PubMed]
[35] Leerach, N., Sitthisak, S., Kitti, T., Teerawattanapong, N., Mahikul, W., Lamlertthon, S., et al. (2024) Association of Serum Interleukin-17 Level and Mycoplasma pneumoniae Pneumonia in Children: A Systematic Review and Meta-analysis. Translational Pediatrics, 13, 1588-1599. [Google Scholar] [CrossRef] [PubMed]
[36] Bose, S., Segovia, J.A., Somarajan, S.R., Chang, T., Kannan, T.R. and Baseman, J.B. (2014) ADP-Ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS Toxin Regulates Inflammasome Activity. mBio, 5, e02186-14. [Google Scholar] [CrossRef] [PubMed]
[37] Berkovich, S., Millian, S.J. and Snyder, R.D. (1970) The Association of Viral and Mycoplasma Infections with Recurrence of Wheezing in the Asthmatic Child. Annals of Allergy, 28, 43-49.
[38] Cassell, G.H. (1998) Infectious Causes of Chronic Inflammatory Diseases and Cancer. Emerging Infectious Diseases, 4, 475-487. [Google Scholar] [CrossRef] [PubMed]
[39] Schwarze, J., Cieslewicz, G., Joetham, A., Ikemura, T., Mäkelä, M.J., Dakhama, A., et al. (2000) Critical Roles for Interleukin-4 and Interleukin-5 during Respiratory Syncytial Virus Infection in the Development of Airway Hyperresponsiveness after Airway Sensitization. American Journal of Respiratory and Critical Care Medicine, 162, 380-386. [Google Scholar] [CrossRef] [PubMed]
[40] Schwarze, J., Makela, M., Cieslewicz, G., Dakhama, A., Lahn, M., Ikemura, T., et al. (1999) Transfer of the Enhancing Effect of Respiratory Syncytial Virus Infection on Subsequent Allergic Airway Sensitization by T Lymphocytes. The Journal of Immunology, 163, 5729-5734. [Google Scholar] [CrossRef] 
[41] Smith, R. and Eviatar, L. (2000) Neurologic Manifestations of Mycoplasma pneumoniae Infections: Diverse Spectrum of Diseases. A Report of Six Cases and Review of the Literature. Clinical Pediatrics, 39, 195-201. [Google Scholar] [CrossRef] [PubMed]
[42] Pönkä, A. (1979) The Occurrence and Clinical Picture of Serologically Verified Mycoplasma pneumoniae Infections with Emphasis on Central Nervous System, Cardiac and Joint Manifestations. Annals of Clinical Research, 11, 1-60.
[43] Feder, H.M., Watkin, T., Cole, S.R. and Quintiliani, R. (1981) Severe Meningoencephalitis: Complicating Mycoplasma pneumoniae Infection in a Child. Archives of Pathology & Laboratory Medicine, 105, 619-621.
[44] Canavan, T.N., Mathes, E.F., Frieden, I. and Shinkai, K. (2015) Mycoplasma pneumoniae-Induced Rash and Mucositis as a Syndrome Distinct from Stevens-Johnson Syndrome and Erythema Multiforme: A Systematic Review. Journal of the American Academy of Dermatology, 72, 239-245.e4. [Google Scholar] [CrossRef] [PubMed]
[45] Khan, F.Y. and Ayassin, M. (2009) Mycoplasma pneumoniae Associated with Severe Autoimmune Hemolytic Anemia: Case Report and Literature Review. Brazilian Journal of Infectious Diseases, 13, 77-79. [Google Scholar] [CrossRef] [PubMed]
[46] Wang, J., Ho, M. and Shen, E. (2004) Mycoplasma pneumoniae Infection Associated with Hemolytic Anemia—Report of One Case. Acta Paediatrica Taiwanica, 45, 293-295.
[47] Khoury, T., Abu Rmeileh, A., Kornspan, J.D., Abel, R., Mizrahi, M. and Nir-Paz, R. (2015) Mycoplasma pneumoniae Pneumonia Associated with Methemoglobinemia and Anemia: An Overlooked Association? Open Forum Infectious Diseases, 2, ofv022. [Google Scholar] [CrossRef] [PubMed]
[48] Davis, C.P. (1988) Isolation of Mycoplasma pneumoniae from Synovial Fluid Samples in a Patient with Pneumonia and Polyarthritis. Archives of Internal Medicine, 148, 969-970. [Google Scholar] [CrossRef] [PubMed]
[49] Arav‐Boger, R., Assia, A., Spirer, Z., Bujanover, Y. and Reif, S. (1995) Cholestatic Hepatitis as a Main Manifestation of Mycoplasma pneumoniae Infection. Journal of Pediatric Gastroenterology and Nutrition, 21, 459-460. [Google Scholar] [CrossRef] 
[50] Andrews, P.A., Lloyd, C.M., Webb, M.C. and Sacks, S.H. (1994) Acute Interstitial Nephritis Associated with Mycoplasma pneumoniae Infection. Nephrology Dialysis Transplantation, 9, 564-566. [Google Scholar] [CrossRef] [PubMed]

为你推荐